share_log

Wolverine Asset Management LLC Grows Stock Holdings in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDU)

Wolverine Asset Management LLC Grows Stock Holdings in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDU)

金刚狼资产管理公司增持智能医药收购公司(纳斯达克代码：IQMDU)
Defense World ·  2022/11/03 06:02

Wolverine Asset Management LLC grew its holdings in shares of Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDU – Get Rating) by 107.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 5,977 shares of the company's stock after purchasing an additional 3,089 shares during the period. Wolverine Asset Management LLC's holdings in Intelligent Medicine Acquisition were worth $60,000 as of its most recent SEC filing.

金刚狼资产管理有限公司(Wolverine Asset Management LLC)根据其最近向美国证券交易委员会披露的数据，第二季度增持了智能医药收购公司(Johnson：IQMDU-GET Rating)的股票，增幅为107.0%。该基金持有5977股该公司股票，在此期间又购买了3,089股。截至最近提交给美国证券交易委员会的文件，金刚狼资产管理有限公司在智能医药收购中持有的股份价值60,000美元。

Separately, Spartan Fund Management Inc. bought a new stake in shares of Intelligent Medicine Acquisition during the first quarter valued at approximately $1,264,000.

另外，斯巴达基金管理公司(Spartan Fund Management Inc.)在第一季度购买了智能医药收购公司的新股，价值约1,264,000美元。

Get
到达
Intelligent Medicine Acquisition
智能医疗采集
alerts:
警报：

Intelligent Medicine Acquisition Price Performance

智能医疗采办性价比

Shares of IQMDU opened at $10.13 on Thursday. The firm has a 50 day moving average of $10.09 and a 200 day moving average of $10.08. Intelligent Medicine Acquisition Corp. has a twelve month low of $9.94 and a twelve month high of $10.30.

周四，IQMDU的股价开盘报10.13美元。该公司的50日移动均线切入位在10.09美元，200日移动均线切入位在10.08美元。智能医药收购公司的股价为9.94美元的12个月低点和10.30美元的12个月高位。

About Intelligent Medicine Acquisition

关于智能医疗采办

(Get Rating)
(获取评级)

Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.

智能医药收购公司没有重大业务。公司专注于与一家或多家企业进行合并、资本换股、资产收购、股票购买、重组或相关业务合并。它打算确定生命科学领域的商业机会。

Further Reading

进一步阅读

  • Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMDU)
  • New Revenue Strategy, Strong Earnings, Apple Remains a Buy
  • Devon Energy Lower After Beating Q3 Views But Slashing Dividend
  • Chesapeake Energy Focus on Natural Gas Leads to Strong Results
  • Are Investors Bailing on Travel America as Diesel Shortages Loom?
  • Sell-Side Interest Drives Mondelez Higher
  • 免费获取StockNews.com关于智能医疗获取的研究报告(IQMDU)
  • 新的收入战略，强劲的收益，苹果仍然是一个买入者
  • Devon Energy股价下跌，此前第三季度业绩好于预期，但大幅削减股息
  • 切萨皮克能源专注于天然气带来强劲业绩
  • 柴油短缺迫在眉睫，投资者是否放弃了美国之旅？
  • 卖方兴趣推动Mondelez走高

Want to see what other hedge funds are holding IQMDU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDU – Get Rating).

想看看还有哪些对冲基金持有IQMDU吗？访问HoldingsChannel.com获取智能医药收购公司(纳斯达克：IQMDU-GET Rating)的最新13F备案文件和内幕交易信息。

Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

接受《智能医药采购日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对智能医药收购和相关公司的最新新闻和分析师评级的每日简要摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发